Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
25.79
-1.40 (-5.15%)
At close: Oct 16, 2025, 4:00 PM EDT
24.64
-1.15 (-4.46%)
Pre-market: Oct 17, 2025, 6:25 AM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.53 billion as of October 17, 2025. Its market cap has increased by 36.95% in one year.
Market Cap
2.53B
Enterprise Value
1.54B
1-Year Change
36.95%
Ranking
Category
Stock Price
$25.79
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.53B, an increase of 672.79%. That is a compound annual growth rate of 43.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 2.53B | 28.40% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |